Activity of faropenem against resistant isolates of Streptococcus pneumoniae

An in vitro study of the activity of 9 agents against 181 US pediatric isolates of Streptococcus pneumoniae identified imipenem and faropenem as the most active agents. Overall, faropenem was the most potent oral agent inhibiting 98% of isolates at 1 μg/mL.

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Diagnostic microbiology and infectious disease 2001-09, Vol.41 (1), p.89-92
Hauptverfasser:	Black, Jennifer A, Moland, Ellen Smith, Chartrand, Stephen A, Thomson, Kenneth S
Format:	Artikel
Sprache:	eng
Schlagworte:	Anti-Bacterial Agents - pharmacology Antibacterial agents Antibiotics. Antiinfectious agents. Antiparasitic agents Atherosclerosis (general aspects, experimental research) beta-Lactams Biological and medical sciences Blood and lymphatic vessels Cardiology. Vascular system Drug Resistance, Multiple, Bacterial Lactams Medical sciences Microbial Sensitivity Tests Pharmacology. Drug treatments Streptococcus pneumoniae - drug effects
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	An in vitro study of the activity of 9 agents against 181 US pediatric isolates of Streptococcus pneumoniae identified imipenem and faropenem as the most active agents. Overall, faropenem was the most potent oral agent inhibiting 98% of isolates at 1 μg/mL.
ISSN:	0732-8893 1879-0070
DOI:	10.1016/S0732-8893(01)00283-8